Neonc Technologies Holdings, Inc. (NTHI): who owns it and who trades it
As of Nov 16, 2026, NTHI insiders reported 1 open-market sale worth $16.8K and 37 purchases worth $2.1M in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Keithly Garnett (CFO), with $16.8K. 1 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Neonc Technologies Holdings
From the latest filingsOverall: more buying than selling. Insiders and famous investors mostly bought. Funds was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns NTHI
21 funds and institutions reported NTHI shares worth $14.3M at the end of Q2 2026, about 13% of the company. The largest holder is Cinctive Capital Management LP with 6.8%.
Funds and institutions (13F) 13%Everyone else 87%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| Cinctive Capital Management LP | 1.61M | 6.75% | $7.3M | +13% |
| Vanguard Capital Management LLC | 504,171 | 2.12% | $2.3M | +134% |
| Bank of America Corp | 224,412 | 0.94% | $1M | -5% |
| Westmount Partners, LLC | 197,178 | 0.83% | $893K | +355% |
| BlackRock, Inc. | 179,850 | 0.76% | $815K | +15% |
| Geode Capital Management, LLC | 166,120 | 0.70% | $753K | +31% |
| Vanguard Fiduciary Trust Co | 91,480 | 0.38% | $414K | +63% |
| State Street Corp | 43,170 | 0.18% | $196K | No change |
| Northern Trust Corp | 35,871 | 0.15% | $162K | +54% |
| Global Retirement Partners, LLC | 27,790 | 0.12% | $126K | New |
| Marshall Wace, LLP | 21,784 | 0.09% | $98.7K | +73% |
| Morgan Stanley | 15,647 | 0.07% | $70.9K | -70% |
| Royal Bank of Canada | 15,625 | 0.07% | $71K | -6% |
| HCR Wealth Advisors | 15,000 | 0.06% | $68K | No change |
| Vanguard Global Advisers, LLC | 4,265 | 0.02% | $19.3K | No change |
| Ancora Advisors LLC | 2,075 | 0.01% | $9.4K | No change |
| Wells Fargo & Company | 2,000 | 0.01% | $9.1K | +33% |
| UBS Group AG | 1,731 | 0.01% | $7.8K | +534% |
| Strategic Wealth Partners, Ltd. | 492 | 0.00% | $2.2K | No change |
| Barclays PLC | 453 | 0.00% | $2.1K | -94% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, NTHI insiders reported $2.1M of open-market purchases and $16.8K of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 13, 2026 | Amir F Heshmatpour | CEO | Purchase | 30,000 | $5.02 | $151K | Form 4 |
| Nov 11, 2026 | Amir F Heshmatpour | CEO | Purchase | 10,000 | $4.49 | $44.9K | Form 4 |
| Nov 11, 2026 | Amir F Heshmatpour | CEO | Purchase | 10,000 | $4.00 | $40K | Form 4 |
| Nov 10, 2026 | Thomas C Chen | Director | Purchase | 2,284 | $4.38 | $10K | Form 4 |
| Nov 10, 2026 | Amir F Heshmatpour | CEO | Purchase | 50,000 | $4.19 | $210K | Form 4 |
| Nov 9, 2026 | Thomas C Chen | Director | Purchase | 2,732 | $3.66 | $10K | Form 4 |
| Nov 9, 2026 | Amir F Heshmatpour | CEO | Purchase | 10,000 | $3.86 | $38.6K | Form 4 |
| Nov 6, 2026 | Amir F Heshmatpour | CEO | Purchase | 40,000 | $3.39 | $136K | Form 4 |
| Nov 5, 2026 | Amir F Heshmatpour | CEO | Purchase | 30,000 | $3.17 | $95K | Form 4 |
| Sep 15, 2026 | Keithly Garnett | CFO | Sale | 5,000 | $3.36 | $16.8K | Form 4 |
| Sep 15, 2026 | Amir F Heshmatpour | CEO | Purchase | 35,000 | $3.30 | $116K | Form 4 |
| Sep 14, 2026 | Amir F Heshmatpour | CEO | Purchase | 15,000 | $3.96 | $59.4K | Form 4 |
| Sep 14, 2026 | Thomas C Chen | CEO | Purchase | 5,242 | $3.82 | $20K | Form 4 |
| Sep 14, 2026 | Keithly Garnett | CFO | Purchase | 257 | $3.89 | $1,000 | Form 4 |
| Sep 11, 2026 | Thomas C Chen | CEO | Purchase | 5,556 | $3.60 | $20K | Form 4 |
| Sep 11, 2026 | Amir F Heshmatpour | CEO | Purchase | 37,000 | $3.67 | $136K | Form 4 |
| Aug 18, 2026 | Thomas C Chen | CEO | Purchase | 12,757 | $5.49 | $70K | Form 4 |
| Aug 18, 2026 | Amir F Heshmatpour | CEO | Purchase | 9,000 | $5.54 | $49.9K | Form 4 |
| Aug 17, 2026 | Thomas C Chen | Director | Purchase | 2,472 | $4.04 | $10K | Form 4 |
| Aug 17, 2026 | Amir F Heshmatpour | CEO | Purchase | 3,000 | $4.37 | $13.1K | Form 4 |
| Aug 14, 2026 | Thomas C Chen | Director | Purchase | 33,787 | $3.85 | $130K | Form 4 |
| Aug 14, 2026 | Amir F Heshmatpour | CEO | Purchase | 12,000 | $3.79 | $45.5K | Form 4 |
| May 1, 2026 | Amir F Heshmatpour | President | Purchase | 10,000 | $4.16 | $41.6K | Form 4 |
| Apr 28, 2026 | Amir F Heshmatpour | President | Purchase | 10,000 | $4.52 | $45.2K | Form 4 |
| Apr 24, 2026 | Thomas C Chen | Director | Purchase | 10,000 | $4.80 | $48K | Form 4 |
| Apr 23, 2026 | Yousha Neman-Ebrahim | Chief Clinical Officer | Purchase | 500 | $4.88 | $2.4K | Form 4 |
| Apr 23, 2026 | Amir F Heshmatpour | President | Purchase | 10,000 | $4.90 | $49K | Form 4 |
| Apr 10, 2026 | Thomas C Chen | Director | Purchase | 948 | $5.17 | $4.9K | Form 4 |
| Apr 10, 2026 | Amir F Heshmatpour | President | Purchase | 10,000 | $4.90 | $49K | Form 4 |
| Apr 9, 2026 | David Suh Jr. | Chief Accounting Officer | Purchase | 200 | $5.00 | $1K | Form 4 |
| Apr 9, 2026 | Amir F Heshmatpour | President | Purchase | 5,000 | $5.19 | $26K | Form 4 |
| Apr 8, 2026 | Amir F Heshmatpour | President | Purchase | 10,000 | $5.61 | $56.1K | Form 4 |
| Apr 6, 2026 | Amir F Heshmatpour | President | Purchase | 5,000 | $6.32 | $31.6K | Form 4 |
| Apr 2, 2026 | Amir F Heshmatpour | President | Purchase | 20,000 | $6.09 | $122K | Form 4 |
| Nov 24, 2025 | Amir F Heshmatpour | President | Purchase | 6,000 | $6.51 | $39.1K | Form 4 |
| Nov 21, 2025 | Amir F Heshmatpour | President | Purchase | 20,000 | $5.98 | $120K | Form 4 |
| Nov 21, 2025 | Amir F Heshmatpour | President | Purchase | 4,000 | $6.50 | $26K | Form 4 |
| Nov 20, 2025 | Yousha Neman-Ebrahim | Chief Clinical Officer | Purchase | 1,100 | $6.69 | $7.4K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Amir F Heshmatpour | President, Director, 10% owner | $1.7M | – | Nov 13, 2026 |
| Thomas C Chen | Chief Scientific Officer, Director, 10% owner | $323K | – | Nov 10, 2026 |
| Keithly Garnett | CFO | $1,000 | $16.8K | Sep 15, 2026 |
| Yousha Neman-Ebrahim | Chief Clinical Officer | $9.8K | – | Apr 23, 2026 |
| David Suh Jr. | Chief Accounting Officer | $1K | – | Apr 9, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
NTHI short interest
Low short interest. 3.5% of NTHI shares are sold short: about 1 share in 28. Over the last 12 reports the number of shares short went up 293%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 920,631 NTHI shares were sold short, 3.5% of the shares outstanding, up 5.0% from the report before. At the average daily volume of 130,875 shares, buying them all back would take about 7.0 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 920,631 | 3.55% | +5% | 130,875 | 7.0 |
| Oct 15, 2026 | 876,682 | 3.38% | +16% | 165,094 | 5.3 |
| Sep 30, 2026 | 757,739 | 2.92% | +45% | 192,992 | 3.9 |
| Sep 15, 2026 | 522,311 | 2.01% | +11% | 207,983 | 2.5 |
| Aug 31, 2026 | 471,450 | 1.82% | -21% | 209,032 | 2.3 |
| Aug 14, 2026 | 597,816 | 2.30% | -3% | 356,504 | 1.7 |
| Jul 31, 2026 | 617,954 | 2.60% | +18% | 51,916 | 11.9 |
| Jul 15, 2026 | 521,841 | 2.19% | +33% | 78,383 | 6.7 |
| Jun 30, 2026 | 391,112 | 1.64% | +45% | 122,339 | 3.2 |
| Jun 15, 2026 | 270,547 | 1.14% | +1% | 97,503 | 2.8 |
| May 29, 2026 | 268,593 | 1.13% | +15% | 47,368 | 5.7 |
| May 15, 2026 | 234,196 | 0.98% | -15% | 138,189 | 1.7 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Neonc Technologies Holdings company events
Neonc Technologies Holdings filed 32 reports on Form 8-K in the last 12 months, 4 of them about an important change (leadership). The latest was on Nov 5, 2026.
- Nov 5, 2026ResultsReleased financial results. Filing
- Nov 3, 2026AnnouncementShared information with investors. Filing
- Oct 22, 2026AnnouncementShared information with investors. Filing
- Oct 15, 2026LeadershipSteven L. Giannotta, M.D., a Class I director, notified NeOnc Technologies Holdings, Inc. of his resignation as a member of the Company’s board of directors, effective October 9, 2026. Filing
- Sep 28, 2026AnnouncementShared information with investors. Filing
- Sep 21, 2026SharesChanged the rights of its shareholders. Filing
- Sep 17, 2026AnnouncementShared information with investors. Filing
- Sep 10, 2026AgreementNeOnc Technologies Holdings, Inc. entered into securities purchase agreements with certain institutional investors relating to the registered direct offering and sale of an aggregate of 2,610,715 shares of the Company’s common stock, par value $0.0001 per share, pre-funded warrants to purchase up… Filing
- Aug 21, 2026LeadershipAmended an earlier report. Of Form 8-K, the Company is filing this Amendment solely to disclose the Board’s determination of Ms. Shomali’s committee assignment. Filing
- Aug 20, 2026VoteReported shareholder vote results. Filing
- Aug 13, 2026AnnouncementShared information with investors. Filing
- Aug 12, 2026AnnouncementShared information with investors. Filing
- Aug 10, 2026ResultsReleased financial results. Filing
- Jul 15, 2026AnnouncementShared information with investors. Filing
- Jul 2, 2026LeadershipMing-Fu (Alan) Chiang, M.D., Ph.D., MBA, a Class II director, notified NeOnc Technologies Holdings, Inc. of his resignation as a member of the Company’s Board of Directors, effective immediately. Filing
- Jun 23, 2026AnnouncementShared information with investors. Filing
- Jun 18, 2026AnnouncementShared information with investors. Filing
- Jun 12, 2026AgreementEntry into a M aterial Definitive Agreement. Filing
- May 18, 2026ResultsReleased financial results. Filing
- Apr 24, 2026AgreementAs previously disclosed, on January 29, 2026, NeOnc Technologies Holdings, Inc. entered into a Securities Purchase Agreement to issue and sell up to 2,222,222 shares of common stock, $0.0001 par value per share of the Company at a per Share purchase price of $7.20 and five-year warrants to purchase… Filing
- Apr 16, 2026AnnouncementShared information with investors. Filing
- Apr 10, 2026AgreementThe Company entered into an Equity Distribution Agreement with BTIG, LLC and A.G.P./Alliance Global Partners to create an “at the market” equity program under which it may sell up to an aggregate of $75 million of shares of the Company’s common stock, par value $0.0001 per share, from time to time… Filing
- Apr 3, 2026ResultsReleased financial results. Filing
- Mar 23, 2026AgreementAs previously disclosed, on January 29, 2026, NeOnc Technologies Holdings, Inc. entered into a Securities Purchase Agreement to issue and sell up to 2,222,222 shares of common stock, $0.0001 par value per share of the Company at a per Share purchase price of $7.20 and five-year warrants to purchase… Filing
- Mar 17, 2026LeadershipThe Board of Directors of the Company appointed David Choi as the Company’s Chief Accounting Officer, effective March 12, 2026. Filing
- Mar 6, 2026AnnouncementShared information with investors. Filing
- Mar 4, 2026AnnouncementNeOnc Technologies Holdings, Inc.’s wholly owned subsidiary, NeOnc Technologies, Inc. and Fox Infused, LLC, a Delaware limited liability company, entered into an Intellectual Property License and Supply Agreement effective July 1, 2022 whereby NeOnc agreed to supply certain products to Fox Infused… Filing
- Mar 3, 2026AgreementAs previously disclosed, on January 29, 2026 NeOnc Technologies Holdings, Inc. entered into a Securities Purchase Agreement to issue and sell up to 2,222,222 shares of common stock, $0.0001 par value per share of the Company at a per Share purchase price of $7.20 and five-year warrants to purchase… Filing
- Feb 27, 2026AnnouncementShared information with investors. Filing
- Jan 29, 2026AgreementNeOnc Technologies Holdings, Inc. entered into a Securities Purchase Agreement to issue and sell up to 2,222,222 shares of common stock, $0.0001 par value per share of the Company at a per Share purchase price of $7.20 and five-year warrants to purchase up to 2,222,222 shares of Common Stock at a… Filing
- Dec 17, 2025AnnouncementShared information with investors. Filing
- Dec 5, 2025AgreementNeOnc Technologies Holdings, Inc. entered into a Securities Purchase Agreement with Saad Naja to issue and sell 111,732 shares of common stock, $0.0001 par value per share of the Company. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Neonc Technologies Holdings financials
Famous investors that hold NTHI
1 of the 50 well-known investors we track reported holding NTHI in their latest 13F filing. The largest position is Israel Englander's, worth $51.3K.
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Israel Englander · Millennium Management | Q3 2026 | 15,053 | $51.3K | 0.0% | New |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named NTHI in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 16, 2026 | Cinctive Capital Management LP | 13G/A | 10.0% |
| Nov 16, 2026 | Cinctive Capital Management LP | 13G/A | 10.0% |
Questions about Neonc Technologies Holdings, Inc. (NTHI) stock
Who owns the most NTHI stock?
The largest reported owner of Neonc Technologies Holdings, Inc. (NTHI) is Cinctive Capital Management LP, with 6.8% of the company. In total, 21 funds and institutions reported holding NTHI at the end of Q2 2026, together about 13% of the shares. See the largest owners.
Are NTHI insiders buying or selling?
In the last 12 months, NTHI insiders reported 37 open-market purchases worth $2.1M and 1 sale worth $16.8K. The latest trade was on Nov 13, 2026. See every trade.
What is the short interest in NTHI?
As of Oct 30, 2026, 920,631 NTHI shares were sold short, 3.5% of the shares outstanding, up 5.0% from the report before. At the average daily volume of 130,875 shares, buying them all back would take about 7.0 trading days (days to cover). See the history.
Which famous investors hold NTHI?
1 of the 50 well-known investors we track reported NTHI in their latest 13F filing, including Israel Englander. The largest position is worth $51.3K. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.